Literature DB >> 7539923

Use of yeast artificial chromosomes (YACs) in studies of mammalian development: production of beta-globin locus YAC mice carrying human globin developmental mutants.

K R Peterson1, Q L Li, C H Clegg, T Furukawa, P A Navas, E J Norton, T G Kimbrough, G Stamatoyannopoulos.   

Abstract

To test whether yeast artificial chromosomes (YACs) can be used in the investigation of mammalian development, we analyzed the phenotypes of transgenic mice carrying two types of beta-globin locus YAC developmental mutants: (i) mice carrying a G-->A transition at position -117 of the A gamma gene, which is responsible for the Greek A gamma form of hereditary persistence of fetal hemoglobin (HPFH), and (ii) beta-globin locus YAC transgenic lines carrying delta- and beta-globin gene deletions with 5' breakpoints similar to those of deletional HPFH and delta beta-thalassemia syndromes. The mice carrying the -117 A gamma G-->A mutation displayed a delayed gamma- to beta-globin gene switch and continued to express A gamma-globin chains in the adult stage of development as expected for carriers of Greek HPFH, indicating that the YAC/transgenic mouse system allows the analysis of the developmental role of cis-acting motifs. The analysis of mice carrying 3' deletions first provided evidence in support of the hypothesis that imported enhancers are responsible for the phenotypes of deletional HPFH and second indicated that autonomous silencing is the primary mechanism for turning off the gamma-globin genes in the adult. Collectively, our results suggest that transgenic mice carrying YAC mutations provide a useful model for the analysis of the control of gene expression during development.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7539923      PMCID: PMC41755          DOI: 10.1073/pnas.92.12.5655

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Autonomous developmental control of human embryonic globin gene switching in transgenic mice.

Authors:  N Raich; T Enver; B Nakamoto; B Josephson; T Papayannopoulou; G Stamatoyannopoulos
Journal:  Science       Date:  1990-11-23       Impact factor: 47.728

2.  A point mutation in the A gamma-globin gene promoter in Greek hereditary persistence of fetal haemoglobin.

Authors:  F S Collins; J E Metherall; M Yamakawa; J Pan; S M Weissman; B G Forget
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

3.  G to A substitution in the distal CCAAT box of the A gamma-globin gene in Greek hereditary persistence of fetal haemoglobin.

Authors:  R Gelinas; B Endlich; C Pfeiffer; M Yagi; G Stamatoyannopoulos
Journal:  Nature       Date:  1985 Jan 24-30       Impact factor: 49.962

4.  Developmental regulation of human fetal-to-adult globin gene switching in transgenic mice.

Authors:  T Enver; N Raich; A J Ebens; T Papayannopoulou; F Costantini; G Stamatoyannopoulos
Journal:  Nature       Date:  1990-03-22       Impact factor: 49.962

5.  Developmental regulation of beta-globin gene switching.

Authors:  O R Choi; J D Engel
Journal:  Cell       Date:  1988-10-07       Impact factor: 41.582

6.  The present status of the heterogeneity of fetal hemoglobin in beta-thalassemia: an attempt to unify some observations in thalassemia and related conditions.

Authors:  T H Huisman; W A Schroeder; G D Efremov; H Duma; B Mladenovski; C B Hyman; E A Rachmilewitz; N Bouver; A Miller; A Brodie; J R Shelton; J B Shelton; G Apell
Journal:  Ann N Y Acad Sci       Date:  1974       Impact factor: 5.691

7.  The breakpoint of a large deletion causing hereditary persistence of fetal hemoglobin occurs within an erythroid DNA domain remote from the beta-globin gene cluster.

Authors:  E A Feingold; B G Forget
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

8.  Human gamma- to beta-globin gene switching in transgenic mice.

Authors:  R R Behringer; T M Ryan; R D Palmiter; R L Brinster; T M Townes
Journal:  Genes Dev       Date:  1990-03       Impact factor: 11.361

9.  Molecular analysis of deletions in the human beta-globin gene cluster: deletion junctions and locations of breakpoints.

Authors:  P S Henthorn; O Smithies; D L Mager
Journal:  Genomics       Date:  1990-02       Impact factor: 5.736

10.  Eastern European (delta beta) zero-thalassemia: molecular characterization of a novel 9.1-kb deletion resulting in high levels of fetal hemoglobin in the adult.

Authors:  A Palena; A Blau; G Stamatoyannopoulos; N P Anagnou
Journal:  Blood       Date:  1994-06-15       Impact factor: 22.113

View more
  47 in total

1.  Engineering EGFP reporter constructs into a 200 kb human beta-globin BAC clone using GET Recombination.

Authors:  M Orford; M Nefedov; J Vadolas; F Zaibak; R Williamson; P A Ioannou
Journal:  Nucleic Acids Res       Date:  2000-09-15       Impact factor: 16.971

2.  Systematic documentation and analysis of human genetic variation in hemoglobinopathies using the microattribution approach.

Authors:  Belinda Giardine; Joseph Borg; Douglas R Higgs; Kenneth R Peterson; Sjaak Philipsen; Donna Maglott; Belinda K Singleton; David J Anstee; A Nazli Basak; Barnaby Clark; Flavia C Costa; Paula Faustino; Halyna Fedosyuk; Alex E Felice; Alain Francina; Renzo Galanello; Monica V E Gallivan; Marianthi Georgitsi; Richard J Gibbons; Piero C Giordano; Cornelis L Harteveld; James D Hoyer; Martin Jarvis; Philippe Joly; Emmanuel Kanavakis; Panagoula Kollia; Stephan Menzel; Webb Miller; Kamran Moradkhani; John Old; Adamantia Papachatzopoulou; Manoussos N Papadakis; Petros Papadopoulos; Sonja Pavlovic; Lucia Perseu; Milena Radmilovic; Cathy Riemer; Stefania Satta; Iris Schrijver; Maja Stojiljkovic; Swee Lay Thein; Jan Traeger-Synodinos; Ray Tully; Takahito Wada; John S Waye; Claudia Wiemann; Branka Zukic; David H K Chui; Henri Wajcman; Ross C Hardison; George P Patrinos
Journal:  Nat Genet       Date:  2011-03-20       Impact factor: 38.330

Review 3.  Control of globin gene expression during development and erythroid differentiation.

Authors:  George Stamatoyannopoulos
Journal:  Exp Hematol       Date:  2005-03       Impact factor: 3.084

4.  Adult stage gamma-globin silencing is mediated by a promoter direct repeat element.

Authors:  Akane Omori; Osamu Tanabe; James Douglas Engel; Akiyoshi Fukamizu; Keiji Tanimoto
Journal:  Mol Cell Biol       Date:  2005-05       Impact factor: 4.272

5.  Genome architecture of the human beta-globin locus affects developmental regulation of gene expression.

Authors:  Susanna Harju; Patrick A Navas; George Stamatoyannopoulos; Kenneth R Peterson
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

Review 6.  Regulation of human fetal hemoglobin: new players, new complexities.

Authors:  Arthur Bank
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

7.  Autonomous silencing as well as competition controls gamma-globin gene expression during development.

Authors:  Man Yu; Hemei Han; Ping Xiang; Qiliang Li; George Stamatoyannopoulos
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

8.  Purification and identification of proteins that bind to the hereditary persistence of fetal hemoglobin -198 mutation in the gamma-globin gene promoter.

Authors:  Ivan A Olave; Catalin Doneanu; Xiangdong Fang; George Stamatoyannopoulos; Qiliang Li
Journal:  J Biol Chem       Date:  2006-11-17       Impact factor: 5.157

9.  Tissue-specific replicating capacity of a chimeric poliovirus that carries the internal ribosome entry site of hepatitis C virus in a new mouse model transgenic for the human poliovirus receptor.

Authors:  Akiko Yanagiya; Seii Ohka; Noriyasu Hashida; Masahito Okamura; Choji Taya; Nobuhiko Kamoshita; Kuniko Iwasaki; Yukari Sasaki; Hiromichi Yonekawa; Akio Nomoto
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a).

Authors:  S P McCormick; J K Ng; S Taylor; L M Flynn; R E Hammer; S G Young
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.